promisia-icon-black


Investors

 

NZX-Listed-positive-RGB-blue-69px      NZX Website

NZX-Listed-positive-RGB-blue-69px      NZX Website

Press Releases and Announcements


promisia offer document 2 15 coverCallaghan Innovation Project Grant

27 April 2017

Download Now


promisia offer document 2 15 coverTGA Listing in Australia (Therapeutic Goods Administration)

27 April 2017

Download Now


promisia offer document 2 15 cover600% Sales Increase

Report of the Chairman and Chief Executive Final

Download Now


promisia-documentPositive Preliminary Findings from a Clinical Trial of Arthrem®
25 May 2015

Promisia Integrative Limited, announced today positive and statistically significant preliminary results from a clinical trial of Arthrem®, a dietary supplement for joint support.

The randomised, double-blind, placebo-controlled, 12 week trial was conducted by the Rheumatology Research Unit at the University of Otago in New Zealand and was partially funded by the New Zealand Government through Callaghan Innovation. Preliminary results show that supplementation with Arthrem® (1 capsule twice daily) provided significant benefits for research participants aged 35-75 with hip and knee osteoarthritis.
Download Now


promisia-documentPublication of Peer-Reviewed Research Paper on Arthrem™
20 January 2015

Mr Malcolm Johnson, Chairman of Promisia Integrative Limited announced today the publication of a peer-reviewed scientific research paper. The paper’s first author is the company’s Principal Scientist Dr Sheena Hunt. The research paper was published by the Journal of Inflammation Research, a recognised and authoritative international journal. 

Download Now

Contact Us

Level 4
22 Panama Street 

Wellington 6011
PO Box 25396, Featherston Street
Wellington 6146
New Zealand

T +64 4 499 5563
E